Navigation Links
New women's health researcher brings $6.8 million in funding to MSU
Date:4/28/2010

GRAND RAPIDS, Mich. West Michigan and Michigan State University have become the new home for a $6.8 million Center for Women's Health and Reproduction Research, thanks to the collaborative efforts of MSU, Spectrum Health and the Van Andel Institute.

Leading infertility researcher and new recruit Asgi T. Fazleabas has been director of a Specialized Cooperative Centers Program in Reproduction and Infertility Research at the University of Illinois, now in its eighth year of funding. Supported by a $6.8 million award by the National Institute of Child Health and Human Development, the center and its funding moved this month to MSU, where Fazleabas is now a professor and an associate chairperson in the Department of Obstetrics, Gynecology and Reproductive Biology.

MSU's new Center for Women's Health and Reproduction Research is one of 15 nationwide and is housed in the Van Andel Institute, also home of the college's $6.8 million Udall Center for Parkinson's Disease Research.

"Dr. Fazleabas brings an extensive international research portfolio in the area of women's reproductive health to the region," said Marsha D. Rappley, dean of MSU's College of Human Medicine. "The collective recruitment efforts of the Spectrum HealthMichigan State University Alliance along with the Van Andel Institute have once again resulted in an internationally renowned center of excellence in Grand Rapids."

Fazleabas, funded by the National Institutes of Health continuously since 1986, is a leading authority in the fields of uterine biology, fertility and endometriosis, a debilitating gynecological medical condition that affects one in 10 women with health care costs of $22 billion a year.

His recruitment was made possible by the MSU-Spectrum alliance, a formal agreement between the two institutions to collaborate on medical school faculty recruitment, research initiatives and facility development.

"Spectrum Health looks forward to the expertise and depth of knowledge that Dr. Fazleabas brings to the women's health area," said Matt Van Vranken, executive vice president of Spectrum Health and president of the Spectrum Health Hospital Group. "A researcher and professor of his caliber is an asset to MSU College of Human Medicine as well as to Spectrum Health and the patients we serve.

"The combination of clinical care, research and academics being established here are significant for our physicians and patients of today and tomorrow."

Fazleabas will continue to serve as the director of the specialized cooperative centers program. Richard Leach, professor and chairperson of the Department of Obstetrics, Gynecology and Reproductive Biology in the College of Human Medicine, also is a principal investigator on the project. Other investigators include Serdar Bulun of Northwestern University and Romana Nowak at the University of Illinois at Urbana-Champaign.


'/>"/>

Contact: Jason Cody
codyja@msu.edu
517-432-0924
Michigan State University
Source:Eurekalert

Related biology news :

1. Study finds blocking angiogenesis signaling from inside cell may lead to serious health problems
2. Youre likely to order more calories at a healthy restaurant
3. UC health news: molecular pathway may predict chemotherapy effectiveness
4. Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring
5. UCR engineers to develop new tool to measure how environmental exposures affect health
6. Researchers developing device to predict proper light exposure for human health
7. Thousands of starving children could be restored to health with peanut butter program
8. Smithsonian researchers develop models to assess wetland health
9. AIBS to cohost symposium on evolution, disease and human health
10. NASA celebrates a decade observing climate impacts on health of worlds oceans
11. Conference to examine role technology can play in helping US manage healthcare costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/25/2016)...   Unisys Corporation (NYSE: UIS ) today announced ... International Airport, New York City , to help ... to enter the United States using passports ... pilot testing of the system at Dulles last year. The ... during January 2016. --> pilot testing of the ...
(Date:1/20/2016)... A market that just keeps on growing. Molecular Diagnostics ... genomics knowledge. Learn all about it in this new ... trends are pushing market growth and company valuations. Trends ... pathogen evolution - next generation sequencing - emergence of ... the role of genetic material in Disease and Health ...
(Date:1/13/2016)... , January 13, 2016 ... has published a new market report titled - Biometric Sensors ... and Forecast, 2015 - 2023. According to the report, the global ... and is anticipated to reach US$1,625.8 mn by 2023, ... 2023. In terms of volume, the biometric sensors market ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... , Feb. 10, 2016 NX Prenatal Inc., ... proprietary NeXosome® technology for early warning of adverse ... most recent study by Dr. Thomas McElrath ... Society for Maternal Fetal Medicine,s (SMFM) annual meeting held ... th , 2016.  The presentation reported initial positive ...
(Date:2/10/2016)... New York, and New York, New York (PRWEB) , ... ... ... Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) today announced that it ... and develop new vaccines and immunotherapies for infectious diseases and cancer. ...
(Date:2/10/2016)... 10, 2016  Allergan plc (NYSE: AGN ) ... Brent Saunders , Allergan,s CEO and President, will be ... session at the RBC Capital Markets Healthcare Conference on ... The New York Palace Hotel in New ... live and can be accessed on Allergan,s Investor Relations ...
(Date:2/10/2016)... ... February 10, 2016 , ... Benchmark ... today the promotion of two long-standing principal investigators (PI) to the roles of ... Research and Development. , Dr. Laurence Chu, a Benchmark Research PI in the ...
Breaking Biology Technology: